Altered levels of complement components associated with non-immediate drug hypersensitivity reactions
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Altered levels of complement components associated with non-immediate drug hypersensitivity reactions
Authors
Keywords
-
Journal
Journal of Immunotoxicology
Volume 17, Issue 1, Pages 1-9
Publisher
Informa UK Limited
Online
2019-12-04
DOI
10.1080/1547691x.2019.1695985
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complement and the Regulation of T Cell Responses
- (2018) Erin E. West et al. Annual Review of Immunology
- Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease
- (2018) Stefanie Haeberle et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The Anti-C1s Antibody TNT003 Prevents Complement Activation in the Skin Induced by Bullous Pemphigoid Autoantibodies
- (2018) Anika Kasprick et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Evaluation of a lymphocyte transformation test and cytokine detection assay to identify phenytoin and carbamazepine provoked DRESS or SJS/TEN in epilepsy patients
- (2018) Pongsathorn Kumkamthornkul et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Complement Activation by Pulp Capping Materials Plays a Significant Role in Both Inflammatory and Pulp Stem Cells' Recruitment
- (2017) Thomas Giraud et al. JOURNAL OF ENDODONTICS
- Interleukin-15 Is Associated with Severity and Mortality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
- (2017) Shih-Chi Su et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Severe cutaneous adverse reactions to drugs
- (2017) Tu Anh Duong et al. LANCET
- Genetic variation inCFHpredicts phenytoin-induced maculopapular exanthema in European-descent patients
- (2017) Mark McCormack et al. NEUROLOGY
- Nonclinical Tools to Assess Risk of Drug Hypersensitivity Reactions
- (2016) J. Whritenour et al. Annual Review of Pharmacology and Toxicology
- The “ins and outs” of complement-driven immune responses
- (2016) Simon Freeley et al. IMMUNOLOGICAL REVIEWS
- The Complement C3a Receptor Contributes to Melanoma Tumorigenesis by Inhibiting Neutrophil and CD4+T Cell Responses
- (2016) Jamileh A. Nabizadeh et al. JOURNAL OF IMMUNOLOGY
- The Complement Inhibitor Factor H Generates an Anti-Inflammatory and Tolerogenic State in Monocyte-Derived Dendritic Cells
- (2016) Rut Olivar et al. JOURNAL OF IMMUNOLOGY
- Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults
- (2016) Derek Y. Hsu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- UK guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis in adults 2016
- (2016) D. Creamer et al. Journal of Plastic Reconstructive and Aesthetic Surgery
- C5a/C5aR Pathway Plays a Vital Role in Brain Inflammatory Injury via Initiating Fgl-2 in Intracerebral Hemorrhage
- (2016) Bangqing Yuan et al. MOLECULAR NEUROBIOLOGY
- T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells
- (2016) G. Arbore et al. SCIENCE
- Role of Complement and Complement Regulatory Proteins in the Complications of Diabetes
- (2015) Pamela Ghosh et al. ENDOCRINE REVIEWS
- The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome
- (2014) T. Ishida et al. ALLERGY
- Systems biology approaches to enhance our understanding of drug hypersensitivity reactions
- (2014) J. R. Perkins et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Desensitization in delayed drug hypersensitivity reactions - an EAACI position paper of the Drug Allergy Interest Group
- (2013) K. Scherer et al. ALLERGY
- Intracellular Complement Activation Sustains T Cell Homeostasis and Mediates Effector Differentiation
- (2013) M. Kathryn Liszewski et al. IMMUNITY
- Disruption of the Complement Anaphylatoxin Receptor C5L2 Exacerbates Inflammation in Allergic Contact Dermatitis
- (2013) R. Wang et al. JOURNAL OF IMMUNOLOGY
- Complement Factor H: A Biomarker for Progression of Cutaneous Squamous Cell Carcinoma
- (2013) Pilvi M. Riihilä et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Human Complement Receptor Type 1/CD35 Is an Epstein-Barr Virus Receptor
- (2013) Javier G. Ogembo et al. Cell Reports
- TNF-α and IFN-γ Are Potential Inducers of Fas-Mediated Keratinocyte Apoptosis through Activation of Inducible Nitric Oxide Synthase in Toxic Epidermal Necrolysis
- (2012) Isabelle Viard-Leveugle et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A protective role of complement component 3 in T cell-mediated skin inflammation
- (2011) Rahul Purwar et al. EXPERIMENTAL DERMATOLOGY
- Participation of Complement 3a receptor (C3aR) in the sensitization phase of Th2 mediated allergic contact dermatitis
- (2011) Margarete Niebuhr et al. EXPERIMENTAL DERMATOLOGY
- Complement: a key system for immune surveillance and homeostasis
- (2010) Daniel Ricklin et al. NATURE IMMUNOLOGY
- The Alternative Complement Pathway Seems to be a UVA Sensor that Leads to Systemic Immunosuppression
- (2009) Michael P.F. Stapelberg et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs
- (2008) T. D. Fernandez et al. ALLERGY
- Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis
- (2008) Wen-Hung Chung et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More